Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, primarily through its Enhaze platform. This technology, based on the rHuPH20 ...

Stocks face downward pressure as Trump reinstates tariffs on steel and aluminum. Tech, airline and biotech stocks weaken while oil prices push oil producer stocks higher.

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the stock. Separately, ...

The Australian stock market has seen modest gains recently, with the ASX200 up 0.25% and sectors like Industrials and Financials showing strong performance. Amidst these movements, the concept of ...

Before market open, Biohaven announced that the U.S. Food and Drug Administration (FDA) had accepted its New Drug Application (NDA) for troriluzole. This is a once-daily oral treatment for adults with ...

The biotechnology sector is filled with high-potential growth stocks. With advancements in artificial intelligence (AI), biotech remains at the cutting edge of medical and scientific innovation, ...

Trinity Biotech plc (TRIB), a leading developer of diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market, has seen its stock price touch a 52-week low, ...

StockNews.com lowered shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a hold rating to a sell rating in a ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $1.05 million, before ...

Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology industries, surprising investors with a $100 million revenue shortfall that led ...